ADAP - Wall Street Estimates - Adaptimmune Therapeutics plc

Healthcare - Biotechnology - NASDAQ - GB

$ 0.54

-2.01 %

$ 23 M

Market Cap

-3.18

P/E

Price Target Average

416.20%

Revenue Forecast Estimate

57.62%

EBIT Estimate

--19.58%

Net Income Estimate

3.67%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Adaptimmune Therapeutics plc

Wall Street analysts predict an average 1-year price target for ADAP of $2.79 , with forecasts ranging from a low of $1 to a high of $4 .

ADAP Lowest Price Target Wall Street Target

1 USD 85.19%

ADAP Average Price Target Wall Street Target

2.79 USD 416.20%

ADAP Highest Price Target Wall Street Target

4 USD 640.74%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free